Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 30 studies | 27% ± 12% | |
| conventional dendritic cell | 20 studies | 32% ± 14% | |
| dendritic cell | 18 studies | 34% ± 14% | |
| endothelial cell | 15 studies | 25% ± 9% | |
| classical monocyte | 15 studies | 22% ± 7% | |
| myeloid cell | 11 studies | 27% ± 9% | |
| microglial cell | 11 studies | 42% ± 15% | |
| monocyte | 9 studies | 23% ± 7% | |
| mononuclear phagocyte | 7 studies | 28% ± 5% | |
| goblet cell | 7 studies | 33% ± 15% | |
| ciliated cell | 7 studies | 23% ± 6% | |
| endothelial cell of artery | 5 studies | 22% ± 7% | |
| alveolar macrophage | 4 studies | 21% ± 6% | |
| capillary endothelial cell | 4 studies | 22% ± 2% | |
| epithelial cell | 4 studies | 36% ± 11% | |
| fibroblast | 4 studies | 23% ± 7% | |
| endothelial cell of vascular tree | 4 studies | 18% ± 4% | |
| hepatocyte | 4 studies | 33% ± 21% | |
| brush cell | 4 studies | 60% ± 17% | |
| squamous epithelial cell | 3 studies | 35% ± 21% | |
| enteroendocrine cell | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7758.87 | 1445 / 1445 | 100% | 99.74 | 183 / 183 |
| breast | 100% | 6997.95 | 459 / 459 | 100% | 162.34 | 1117 / 1118 |
| lung | 100% | 7148.81 | 578 / 578 | 100% | 111.84 | 1152 / 1155 |
| intestine | 100% | 6345.16 | 966 / 966 | 100% | 107.61 | 525 / 527 |
| stomach | 100% | 4964.24 | 359 / 359 | 99% | 108.40 | 284 / 286 |
| liver | 100% | 7273.24 | 226 / 226 | 99% | 91.28 | 403 / 406 |
| uterus | 100% | 4879.38 | 170 / 170 | 99% | 82.16 | 454 / 459 |
| ovary | 100% | 5262.07 | 180 / 180 | 99% | 79.74 | 424 / 430 |
| thymus | 100% | 4797.60 | 652 / 653 | 99% | 98.59 | 597 / 605 |
| kidney | 100% | 4241.07 | 89 / 89 | 98% | 81.02 | 885 / 901 |
| prostate | 100% | 3436.27 | 244 / 245 | 99% | 63.76 | 495 / 502 |
| bladder | 100% | 3241.67 | 21 / 21 | 98% | 80.50 | 492 / 504 |
| skin | 99% | 4335.15 | 1795 / 1809 | 96% | 70.32 | 451 / 472 |
| pancreas | 95% | 2322.82 | 311 / 328 | 99% | 101.98 | 176 / 178 |
| adrenal gland | 100% | 5355.18 | 258 / 258 | 88% | 43.42 | 203 / 230 |
| brain | 61% | 1349.10 | 1612 / 2642 | 88% | 52.77 | 619 / 705 |
| adipose | 100% | 7773.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 8308.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4087.05 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 79.99 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.73 | 1 / 1 |
| muscle | 100% | 3487.71 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 90% | 2250.96 | 771 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 63.57 | 25 / 29 |
| eye | 0% | 0 | 0 / 0 | 79% | 30.04 | 63 / 80 |
| peripheral blood | 74% | 5061.00 | 683 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005898 | Cellular component | interleukin-13 receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0019955 | Molecular function | cytokine binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0004896 | Molecular function | cytokine receptor activity |
| Gene name | IL13RA1 |
| Protein name | Interleukin 13 receptor, alpha 1 Interleukin 13 receptor subunit alpha 1 Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1) |
| Synonyms | IL13RA IL13R |
| Description | FUNCTION: Binds with low affinity to interleukin-13 (IL13). Together with IL4RA can form a functional receptor for IL13. Also serves as an alternate accessory protein to the common cytokine receptor gamma chain for interleukin-4 (IL4) signaling, but cannot replace the function of IL2RG in allowing enhanced interleukin-2 (IL2) binding activity. |
| Accessions | ENST00000652600.1 ENST00000371666.8 [P78552-1] Q96BB4 P78552 A0A494C1C4 ENST00000371642.1 [P78552-2] |